CLINICAL_TRIALS
trial_result
· 2015-10-12
Clinical Trial Update: Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS) [Phase 3]
Summary
Phase 3 study of YM060 in diarrhea-predominant irritable bowel syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Irritable Bowel Syndrome | Phase 3 | Status: COMPLETED